X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 65 filers reported holding X4 PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $4,623,000 | +33.9% | 536,962 | 0.0% | 0.07% | +45.8% |
| Q4 2020 | $3,453,000 | -8.8% | 536,962 | -4.0% | 0.05% | -30.4% |
| Q3 2020 | $3,788,000 | -27.3% | 559,494 | 0.0% | 0.07% | -32.4% |
| Q2 2020 | $5,214,000 | -13.4% | 559,494 | -7.1% | 0.10% | -46.3% |
| Q1 2020 | $6,023,000 | +108.3% | 602,274 | +122.8% | 0.19% | +115.9% |
| Q4 2019 | $2,892,000 | -52.4% | 270,292 | -43.5% | 0.09% | -75.7% |
| Q3 2019 | $6,077,000 | -53.0% | 478,107 | -44.5% | 0.36% | -47.8% |
| Q2 2019 | $12,921,000 | – | 861,393 | – | 0.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 311,492 | $2,682,000 | 3.48% |
| Sio Capital Management, LLC | 804,597 | $6,928,000 | 1.41% |
| Bain Capital Life Sciences Investors, LLC | 2,119,540 | $18,249,000 | 1.03% |
| SV Health Investors, LLC | 311,490 | $2,682,000 | 1.00% |
| Monashee Investment Management LLC | 574,712 | $4,948,000 | 0.76% |
| Ikarian Capital, LLC | 2,614,988 | $22,515,000 | 0.76% |
| Abingworth LLP | 229,885 | $1,956,000 | 0.68% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $2,884,000 | 0.67% |
| BVF INC/IL | 1,091,579 | $9,398,000 | 0.35% |
| Endurant Capital Management LP | 151,996 | $1,309,000 | 0.34% |